Загрузка...
Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan
CONTEXT: Somapacitan is a long-acting growth hormone (GH) in development for once-weekly treatment of GH deficiency (GHD). Optimal monitoring of insulin-like growth factor-I (IGF-I) levels must account for weekly IGF-I fluctuations following somapacitan administration. OBJECTIVE: To develop and asse...
Сохранить в:
| Опубликовано в: : | J Clin Endocrinol Metab |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7823237/ https://ncbi.nlm.nih.gov/pubmed/33313798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa775 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|